comparemela.com

Latest Breaking News On - Pharmala biotech holdings inc stock exchange - Page 1 : comparemela.com

PharmAla Awarded Research Grant by Ontario Centre for Innovation

OCI will support Pharmala’s In-Silico Modeling Partnership with University of WindsorTORONTO, June 09, 2023 PharmAla Biotech Holdings Inc. , a biotechnology company focused on the. | June 9, 2023

United statesNicholas kadyshDavid purcellNick kadyshHarpreet kaurUniversity of windsorSilico modeling partnershipPharmala biotech holdings incRegulation services providerClinical researchNeither the canadian securities exchangeDrug administrationOntario centre for innovationOntario centre of innovationIn silico modeling partnershipAla biotech holdings

Canadian Investment Regulatory Organization Trading Halt - MDMA

VANCOUVER, BC, June 9, 2023 /CNW/ - The following issues have been halted by CIRO: Company: Pharmala Biotech Holdings Inc. CSE Symbol: MDMA All Issues: Yes Reason: Pending News Halt Time. | June 9, 2023

British columbiaPharmala biotech holdings incCanadian investment regulatory organizationInvestment regulatory organizationCanada newswirePharmala biotech holdings inc stock exchangePress releaseEnding mdma ca71719l1067

PharmAla Biotech and Shaman Pharma Granted First Ever Special Access Program Authorization for MDMA

This authorization is the first authorized treatment of a patient with MDMA outside of a clinical trial in Canadian historyVANCOUVER, British Columbia, May 16, 2023 PharmAla Biotech Holdings. | May 16, 2023

United kingdomBritish columbiaAlexandre grenierNick kadyshNicholas kadyshAccess programNeither the canadian securities exchangeRegulation services providerHealth canada controlled drugsPharmala biotech holdings incCcrest laboratories incShaman pharma corpHealth canada special access programHealth canadaAla biotech holdingsShaman pharma

PharmAla Biotech : to form Australian Psychedelics Joint Venture with Vitura Health

CORTEXA TO BE THE LEADING SUPPLIER OF MDMA AND PSILOCYBIN IN AUSTRALIA Vancouver, BC - May 1, 2023 - PharmAla Biotech Holdings Inc. is pleased to announce the establishment of. | May 1, 2023

British columbiaNick kadyshRodney cocksPharmala biotech holdings incVitura health limitedCortexa pty ltdAla biotech holdingsAustralian based vitura health limitedAuthorised prescribersPsilocybin productsJoint venturePharmala biotechGuy headleyPharmala biotech holdings inc stock exchangePress releaseStablishment mdma ca71719l1067

PharmAla Biotech and Filament Health Announce Release of GMP MDMA Capsules

PharmAla contracted Filament subsidiary Psilo Scientific to manufacture the drug product for distribution to clinical trial customers and authorized patientsVANCOUVER, British Columbia, April 11,. | April 11, 2023

British columbiaUnited kingdomBenjamin lightburnNicholas kadyshNick kadyshFilament health corpPharmala biotech holdings incFounder of filament healthHealth canadaFilament healthPsilo scientificAla biotech holdingsMetro vancouverPharmaceutical ingredientBenzinga psychedelics capital conferencePharmala biotech holdings inc stock exchange

vimarsana © 2020. All Rights Reserved.